AFP-L3curative treatmenthepatocellular carcinomaHCCBCLC 0tertiary referral centerchronic liver disease
… 0 from BCLC A (AUC 0.767; 95% CI 0.559–0.974; p = 0.039). AFP, AFP-L3, and GALAD showed no significant discriminatory ability between…
1articles mentioning drugs
4drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: AFP-L3 ×
AFP-L3
This drug is selected. Its supporting articles are shown below.